비결핵항산균 폐질환의 면역 발병 기전

키워드

참고문헌 (71)

1. Lee H, "Epidemiology of nontuberculous mycobacterial infection, South Korea, 2007-2016", Emerg Infect Dis, 25, pp.569~572 (2019)
2. Kwon YS, "Diagnosis and treatment of nontuberculous mycobacterial lung disease", J Korean Med Sci, 31, pp.649~659 (2016)
3. Matsuyama M, "Pathophysiology of pulmonary nontuberculous mycobacterial(NTM)disease", Respir Investig, 61, pp.135~148 (2023)
4. Abe Y, "Host immune response and novel diagnostic approach to NTM infections", Int J Mol Sci, 21, pp.4351~ (2020)
5. Honda JR, "Global environmental nontuberculous mycobacteria and their contemporaneous manmade and natural niches", Front Microbiol, 9, pp.2029~ (2018)
6. Muñoz-Egea MC, "Mycobacterium biofilms", Biofilm, 5, pp.100107~ (2023)
7. "Pathogenesis of nontuberculous mycobacterial infections" (2023)[URL]
8. Sousa S, "Nontuberculous mycobacteria pathogenesis and biofilm assembly", Int J Mycobacteriol, 4, pp.36~43 (2015)
9. Zamora N, "In-vitro evaluation of the adhesion to polypropylene sutures of non-pigmented, rapidly growing mycobacteria", Clin Microbiol Infect, 13, pp.902~907 (2007)
10. Schorey JS, "The mycobacterial glycopeptidolipids : structure, function, and their role in pathogenesis", Glycobiology, 18, pp.832~841 (2008)
11. Hall-Stoodley L, "Bacterial biofilms : from the natural environment to infectious diseases", Nat Rev Microbiol, 2, pp.95~108 (2004)
12. Rhoades ER, "Mycobacterium abscessus glycopeptidolipids mask underlying cell wall phosphatidyl-myo-inositol mannosides blocking induction of human macrophage TNF-alpha by preventing interaction with TLR2", J Immunol, 183, pp.1997~2007 (2009)
13. Rodríguez-Sevilla G, "Non-tuberculous Mycobacteria multispecies biofilms in cystic fibrosis : development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model", Int J Med Microbiol, 308, pp.413~423 (2018)
14. Rodríguez-Sevilla G, "Antimicrobial treatment provides a competitive advantage to Mycobacterium abscessus in a dual-species biofilm with Pseudomonas aeruginosa", Antimicrob Agents Chemother, 63, pp.e01547-19~ (2019)
15. Honda JR, "Pathogenesis and risk factors for nontuberculous mycobacterial lung disease", Clin Chest Med, 36, pp.1~11 (2015)
16. Puzo G, "The carbohydrate-and lipid-containing cell wall of mycobacteria, phenolic glycolipids : structure and immunological properties", Crit Rev Microbiol, 17, pp.305~327 (1990)
17. Tran T, "A paucity of knowledge regarding nontuberculous mycobacterial lipids compared to the tubercle bacillus", Tuberculosis(Edinb), 115, pp.96~107 (2019)
18. Maeda N, "The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan", J Biol Chem, 278, pp.5513~5516 (2003)
19. Vignal C, "Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-alpha and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism", J Immunol, 171, pp.2014~2023 (2003)
20. Wieland CW, "Non-mannose-capped lipoarabinomannan induces lung inflammation via toll-like receptor 2", Am J Respir Crit Care Med, 170, pp.1367~1374 (2004)
21. Freeman R, "Roles for cell wall glycopeptidolipid in surface adherence and planktonic dispersal of Mycobacterium avium", Appl Environ Microbiol, 72, pp.7554~7558 (2006)
22. Byrd TF, "Preliminary characterization of a Mycobacterium abscessus mutant in human and murine models of infection", Infect Immun, 67, pp.4700~4707 (1999)
23. Sanguinetti M, "Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis", J Clin Microbiol, 39, pp.816~819 (2001)
24. Torrelles JB, "Characterization of virulence, colony morphotype and the glycopeptidolipid of Mycobacterium avium strain 104", Tuberculosis(Edinb), 82, pp.293~300 (2002)
25. Pedrosa J, "Characterization of the virulence of Mycobacterium avium complex(MAC)isolates in mice", Clin Exp Immunol, 98, pp.210~216 (1994)
26. Schaefer WB, "Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice", Am Rev Respir Dis, 102, pp.499~506 (1970)
27. Nishimura T, "The rough colony morphotype of Mycobacterium avium exhibits high virulence in human macrophages and mice", J Med Microbiol, 69, pp.1020~1033 (2020)
28. Sweet L, "Glycopeptidolipids from Mycobacterium avium promote macrophage activation in a TLR2-and MyD88-dependent manner", J Leukoc Biol, 80, pp.415~423 (2006)
29. Takegaki Y, "Effect of serotype specific glycopeptidolipid(GPL)isolated from Mycobacterium avium complex(MAC)on phagocytosis and phagosome-lysosome fusion of human peripheral blood monocytes", Kekkaku, 75, pp.9~18 (2000)
30. Cebula BR, "Mycobacterium avium serovars 2 and 8 infections elicit unique activation of the host macrophage immune responses", Eur J Clin Microbiol Infect Dis, 31, pp.3407~3412 (2012)
31. McGarvey J, "Pathogenesis of nontuberculous mycobacteria infections", Clin Chest Med, 23, pp.569~583 (2002)
32. Bermudez LE, "Mycobacterium tuberculosis invades and replicates within type II alveolar cells", Infect Immun, 64, pp.1400~1406 (1996)
33. Lin Y, "Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis", Infect Immun, 66, pp.1121~1126 (1998)
34. Abbas AK, "핵심면역학" (2020), 법문에듀케이션
35. Awuh JA, "Molecular basis of mycobacterial survival in macrophages", Cell Mol Life Sci, 74, pp.1625~1648 (2017)
36. Gordon S, "Phagocytosis : an immunobiologic process", Immunity, 44, pp.463~475 (2016)
37. Shamaei M, "Nontuberculous Mycobacteria, macrophages, and host innate immune response", Infect Immun, 89, pp.e0081220~ (2021)
38. Shin DM, "Mycobacterium abscessus activates the macrophage innate immune response via a physical and functional interaction between TLR2 and dectin-1", Cell Microbiol, 10, pp.1608~1621 (2008)
39. Kerscher B, "The dectin-2 family of C-type lectin-like receptors : an update", Int Immunol, 25, pp.271~277 (2013)
40. Yonekawa A, "Dectin-2 is a direct receptor for mannose-capped lipoarabinomannan of mycobacteria", Immunity, 41, pp.402~413 (2014)
41. Kleinnijenhuis J, "Innate immune recognition of Mycobacterium tuberculosis", Clin Dev Immunol, 2011, pp.405310~ (2011)
42. Yu X, "Navigating through the maze of TLR2mediated signaling network for better mycobacterium infection control", Biochimie, 102, pp.1~8 (2014)
43. Sampaio EP, "Mycobacterium abscessus and M. avium trigger Toll-like receptor 2 and distinct cytokine response in human cells", Am J Respir Cell Mol Biol, 39, pp.431~439 (2008)
44. Lee SJ, "The Mycobacterium avium subsp. Paratuberculosis protein MAP1305 modulates dendritic cell-mediated T cell proliferation through Toll-like receptor-4", BMB Rep, 47, pp.115~120 (2014)
45. Lee SJ, "Mycobacterium abscessus MAB2560 induces maturation of dendritic cells via Toll-like receptor 4 and drives Th1 immune response", BMB Rep, 47, pp.512~517 (2014)
46. Shimada K, "Involvement of mannose receptor in glycopeptidolipid-mediated inhibition of phagosome-lysosome fusion", Microbiol Immunol, 50, pp.243~251 (2006)
47. Kano H, "Serotype-specific modulation of human monocyte functions by glycopeptidolipid(GPL)isolated from Mycobacterium avium complex", Biol Pharm Bull, 28, pp.335~339 (2005)
48. Roux AL, "The distinct fate of smooth and rough Mycobacterium abscessus variants inside macrophages", Open Biol, 6, pp.160185~ (2016)
49. Sia JK, "Immunology of Mycobacterium tuberculosis Infections", Microbiol Spectr, 7 (2019)[DOI]
50. Martin CJ, "Efferocytosis is an innate antibacterial mechanism", Cell Host Microbe, 12, pp.289~300 (2012)
51. Chen M, "A mechanism of virulence : virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis", J Immunol, 176, pp.3707~3716 (2006)
52. Behar SM, "Evasion of innate immunity by Mycobacterium tuberculosis : is death an exit strategy?", Nat Rev Microbiol, 8, pp.668~674 (2010)
53. Early J, "Mycobacterium avium uses apoptotic macrophages as tools for spreading", Microb Pathog, 50, pp.132~139 (2011)
54. Helguera-Repetto AC, "Differential macrophage response to slow-and fast-growing pathogenic mycobacteria", Biomed Res Int, 2014, pp.916521~ (2014)
55. Appelberg R, "Host and bacterial factors control the Mycobacterium avium-induced chronic peritoneal granulocytosis in mice", Clin Exp Immunol, 83, pp.231~236 (1991)
56. Petrofsky M, "Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1beta and have a putative role in early host response", Clin Immunol, 91, pp.354~358 (1999)
57. Bermudez LE, "Treatment with recombinant granulocyte colony-stimulating factor(filgrastin)stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice", Immunology, 94, pp.297~303 (1998)
58. Appelberg R, "Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and-dependent phases of Mycobacterium avium infection", Infect Immun, 62, pp.3962~3971 (1994)
59. Kato T, "Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction", J Immunol, 156, pp.3932~3938 (1996)
60. Altare F, "Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency", Science, 280, pp.1432~1435 (1998)
61. Dorman SE, "Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection", J Clin Invest, 101, pp.2364~2369 (1998)
62. Flórido M, "Characterization of the deregulated immune activation occurring at late stages of mycobacterial infection in TNF-deficient mice", J Immunol, 179, pp.7702~7708 (2007)
63. Winthrop KL, "Mycobacterial diseases and antitumour necrosis factor therapy in USA", Ann Rheum Dis, 72, pp.37~42 (2013)
64. Lim A, "Susceptibility to pulmonary disease due to Mycobacterium avium-intracellulare complex may reflect low IL-17 and high IL-10 responses rather than Th1 deficiency", Clin Immunol, 137, pp.296~302 (2010)
65. Kim SY, "Importance of reciprocal balance of T cell immunity in Mycobacterium abscessus complex lung disease", PLoS One, 9, pp.e109941~ (2014)
66. Wu UI, "Patients with idiopathic pulmonary nontuberculous mycobacterial disease have normal Th1", Th2 cytokine responses but diminished Th17 cytokine and enhanced granulocyte-macrophage colony-stimulating factor production, 2019, pp.6, ofz484~
67. Ratnatunga CN, "The rise of non-tuberculosis mycobacterial lung disease", Front Immunol, 11, pp.303~ (2020)
68. Greinert U, "Low in vitro production of interferon-gamma and tumor necrosis factor-alpha in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria", J Clin Immunol, 20, pp.445~452 (2000)
69. Tsuyuguchi I, "Mycobacterium avium-Mycobacterium intracellular complex-induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity", Infect Immun, 58, pp.1369~1378 (1990)
70. Bermudez LE, "Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells", Infect Immun, 67, pp.3108~3111 (1999)
71. Gilbertson B, "Anergy, IFN-gamma production, and apoptosis in terminal infection of mice with Mycobacterium avium", J Immunol, 163, pp.2073~2080 (1999)

관련 논문AI추천